An investor consortium including WhiteOak Capital Management, Siguler Guff, and Creador has acquired approximately 10% of La Renon Healthcare for $1.2 billion. This deal involves stake dilution by promoters and existing investors, with Creador taking a significant portion. The valuation reflects a substantial jump since previous funding rounds.
